FIRST LINE TREATMENT

Clinical trials for FIRST LINE TREATMENT explained in plain language.

Never miss a new study

Get alerted when new FIRST LINE TREATMENT trials appear

Sign up with your email to follow new studies for FIRST LINE TREATMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Can a targeted pill boost Chemo's power against a rare blood cancer?

Disease control Not yet recruiting

This trial is testing whether adding an experimental targeted drug, SHR2554, to standard chemotherapy (liposomal mitoxantrone) can improve outcomes for people with peripheral T-cell lymphoma (PTCL) who have not yet been treated. The study involves about 44 adults with certain PTC…

Matched conditions: FIRST LINE TREATMENT

Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Jul 26, 2026 00:00 UTC

FIRST LINE TREATMENT

Get alerted when new FIRST LINE TREATMENT trials appear

Can a targeted pill boost Chemo's power against a rare blood cancer?